NAT2 slow acetylator is associated with anti-tuberculosis drug-induced liver injury severity in indonesian population

Pharmacogenomics, Ahead of Print.

Source: Future Medicine: Pharmacogenomics - November 7, 2019 Category: Genetics & Stem Cells Authors: Rika Yuliwulandari Kinasih Prayuni Retno Wilujeng Susilowati Subagyo Soedarsono Abdul Salam M Sofro Katsushi Tokunaga Jae-Gook Shin Source Type: research